293 related articles for article (PubMed ID: 27233924)
41. Management of organic impurities in small molecule medicinal products: Deriving safe limits for use in early development.
Harvey J; Fleetwood A; Ogilvie R; Teasdale A; Wilcox P; Spanhaak S
Regul Toxicol Pharmacol; 2017 Mar; 84():116-123. PubMed ID: 28038978
[TBL] [Abstract][Full Text] [Related]
42. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
[TBL] [Abstract][Full Text] [Related]
43. Determination of compound-specific acceptable daily intakes for 11 mutagenic carcinogens used in pharmaceutical synthesis.
Ellis P; Kenyon M; Dobo K
Regul Toxicol Pharmacol; 2013 Mar; 65(2):201-13. PubMed ID: 23228434
[TBL] [Abstract][Full Text] [Related]
44. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process.
Giordani A; Kobel W; Gally HU
Eur J Pharm Sci; 2011 May; 43(1-2):1-15. PubMed ID: 21420491
[TBL] [Abstract][Full Text] [Related]
45. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
Dekant W; Melching-Kollmuss S; Kalberlah F
Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
[TBL] [Abstract][Full Text] [Related]
46. Application of the threshold of toxicological concern concept to pharmaceutical manufacturing operations.
Dolan DG; Naumann BD; Sargent EV; Maier A; Dourson M
Regul Toxicol Pharmacol; 2005 Oct; 43(1):1-9. PubMed ID: 16099564
[TBL] [Abstract][Full Text] [Related]
47. Classification of dermal sensitizers in pharmaceutical manufacturing.
Winkler GC; Perino C; Araya SH; Bechter R; Kuster M; Lovsin Barle E
Regul Toxicol Pharmacol; 2015 Aug; 72(3):501-5. PubMed ID: 26028366
[TBL] [Abstract][Full Text] [Related]
48. Toxicological evaluation of ergocalciferol, cholecalciferol, and their metabolites by a category approach.
Tugcu G; Charehsaz M; Aydın A
Drug Chem Toxicol; 2021 Nov; 44(6):661-667. PubMed ID: 31412708
[TBL] [Abstract][Full Text] [Related]
49. Derivation of an occupational exposure limit for an inhalation analgesic methoxyflurane (Penthrox(®)).
Frangos J; Mikkonen A; Down C
Regul Toxicol Pharmacol; 2016 Oct; 80():210-25. PubMed ID: 27181451
[TBL] [Abstract][Full Text] [Related]
50. Exposure-triggered reproductive toxicity testing under the REACH legislation: a proposal to define significant/relevant exposure.
Bernauer U; Heinemeyer G; Heinrich-Hirsch B; Ulbrich B; Gundert-Remy U
Toxicol Lett; 2008 Jan; 176(1):68-76. PubMed ID: 18068317
[TBL] [Abstract][Full Text] [Related]
51. Setting occupational exposure limits for unstudied pharmaceutical intermediates using an in vitro parallelogram approach.
Maier MS
Toxicol Mech Methods; 2011 Feb; 21(2):76-85. PubMed ID: 20156007
[TBL] [Abstract][Full Text] [Related]
52. Determination of a site-specific reference dose for methylmercury for fish-eating populations.
Shipp AM; Gentry PR; Lawrence G; Van Landingham C; Covington T; Clewell HJ; Gribben K; Crump K
Toxicol Ind Health; 2000 Nov; 16(9-10):335-438. PubMed ID: 11762928
[TBL] [Abstract][Full Text] [Related]
53. Considerations when deriving compound-specific limits for extractables and leachables from pharmaceutical products: Four case studies.
Parris P; Martin EA; Stanard B; Glowienke S; Dolan DG; Li K; Binazon O; Giddings A; Whelan G; Masuda-Herrera M; Bercu J; Broschard T; Bruen U; Callis CM; Stults CLM; Erexson GL; Cruz MT; Nagao LM
Regul Toxicol Pharmacol; 2020 Dec; 118():104802. PubMed ID: 33038429
[TBL] [Abstract][Full Text] [Related]
54. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
Araya S; Lovsin-Barle E; Glowienke S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
[TBL] [Abstract][Full Text] [Related]
55. RIFM fragrance ingredient safety assessment, linalyl isobutyrate, CAS registry number 78-35-3.
Api AM; Belsito D; Bhatia S; Bruze M; Calow P; Dagli ML; Dekant W; Fryer AD; Kromidas L; La Cava S; Lalko JF; Lapczynski A; Liebler DC; Miyachi Y; Politano VT; Ritacco G; Salvito D; Schultz TW; Shen J; Sipes IG; Wall B; Wilcox DK
Food Chem Toxicol; 2015 Oct; 84 Suppl():S76-87. PubMed ID: 26423640
[TBL] [Abstract][Full Text] [Related]
56. RIFM fragrance ingredient safety assessment, Linalyl isovalerate, CAS Registry Number 1118-27-0.
Api AM; Belsito D; Bhatia S; Bruze M; Calow P; Dagli ML; Dekant W; Fryer AD; Kromidas L; La Cava S; Lalko JF; Lapczynski A; Liebler DC; Miyachi Y; Politano VT; Ritacco G; Salvito D; Schultz TW; Shen J; Sipes IG; Wall B; Wilcox DK
Food Chem Toxicol; 2015 Oct; 84 Suppl():S88-99. PubMed ID: 26334794
[TBL] [Abstract][Full Text] [Related]
57. Correlation of chemical structure with reproductive and developmental toxicity as it relates to the use of the threshold of toxicological concern.
Laufersweiler MC; Gadagbui B; Baskerville-Abraham IM; Maier A; Willis A; Scialli AR; Carr GJ; Felter SP; Blackburn K; Daston G
Regul Toxicol Pharmacol; 2012 Feb; 62(1):160-82. PubMed ID: 22019814
[TBL] [Abstract][Full Text] [Related]
58. Revision of the ICH guideline on detection of toxicity to reproduction for medicinal products: SWOT analysis.
Barrow P
Reprod Toxicol; 2016 Sep; 64():57-63. PubMed ID: 27046733
[TBL] [Abstract][Full Text] [Related]
59. Human health risk assessment of chloroxylenol in liquid hand soap and dishwashing soap used by consumers and health-care professionals.
Yost LJ; Rodricks JD; Turnbull D; DeLeo PC; Nash JF; Quiñones-Rivera A; Carlson PA
Regul Toxicol Pharmacol; 2016 Oct; 80():116-24. PubMed ID: 27316554
[TBL] [Abstract][Full Text] [Related]
60. Establishing powder-handling workflow practices and standard operating procedures: compounding pharmacy and safety.
Prince B; Lundevall J
Int J Pharm Compd; 2014; 18(3):222-6. PubMed ID: 25306770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
